Literature DB >> 27008631

Factors Associated with Higher Pro-Inflammatory Tumor Necrosis Factor-α Levels in Young Women with Type 1 Diabetes.

K K Danielson1, R S Monson1, T J LeCaire2.   

Abstract

AIMS: While cytokines play a role in the etiology of type 1 diabetes, cytokines later in the disease are less understood. We therefore investigated associations of pro-inflammatory tumor necrosis factor-α levels measured at prolonged disease duration with C-peptide at diagnosis, long-term glycemic control, diabetes duration, clinical factors, and health behaviors.
METHODS: Data and blood were collected during an ancillary study to the longitudinal Wisconsin Diabetes Registry, a population-based cohort followed since diagnosis of type 1 diabetes. The ancillary study was conducted at 13-18 years diabetes duration, and enrolled premenopausal women age 18-45 years (n=87).
RESULTS: Higher tumor necrosis factor-α levels at 13-18 years diabetes duration were independently associated with longer duration (p=0.0004) and worse current renal function (p=0.02). Additionally, diabetes duration modified both of the positive associations of tumor necrosis factor-α levels (both interactions p≤0.01) with mean glycemic control during the previous 10 years (significant only in women with longer durations) and current daily caffeine intake (significant only in women with shorter durations). In women with C-peptide measured at diagnosis (n=50), higher tumor necrosis factor-α levels at 13-18 years duration were associated with lower C-peptide (p=0.01), independent of glycemic control during the previous 10 years.
CONCLUSIONS: Lower residual C-peptide at diagnosis and poor long-term glycemic control independently predicted higher pro-inflammatory tumor necrosis factor-α levels years later. The novel relationship with C-peptide needs confirmation in a larger cohort. Given the association between tumor necrosis factor-α and diabetes complications, further longitudinal studies may help clarify the potentially complex associations between glycemic control, inflammatory cytokines, and complications. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27008631      PMCID: PMC4849860          DOI: 10.1055/s-0035-1569374

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  41 in total

1.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors:  David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

2.  Inflammatory markers are increased in youth with type 1 diabetes: the SEARCH Case-Control study.

Authors:  Janet K Snell-Bergeon; Nancy A West; Elizabeth J Mayer-Davis; Angela D Liese; Santica M Marcovina; Ralph B D'Agostino; Richard F Hamman; Dana Dabelea
Journal:  J Clin Endocrinol Metab       Date:  2010-04-06       Impact factor: 5.958

3.  Association between age, IL-10, IFNγ, stimulated C-peptide and disease progression in children with newly diagnosed Type 1 diabetes.

Authors:  A Kaas; C Pfleger; A V Kharagjitsingh; N C Schloot; L Hansen; K Buschard; B P C Koeleman; B O Roep; H B Mortensen; B Z Alizadeh
Journal:  Diabet Med       Date:  2012-06       Impact factor: 4.359

4.  The tumour necrosis factor (TNF)-alpha system is activated in accordance with pulse pressure in normotensive subjects with type 1 diabetes mellitus.

Authors:  J M González-Clemente; G Giménez-Pérez; C Richart; M Broch; A Caixàs; A Megia; O Giménez-Palop; I Simón; D Mauricio; J Vendrell
Journal:  Eur J Endocrinol       Date:  2005-11       Impact factor: 6.664

5.  Few differences in cytokines between patients newly diagnosed with type 1 diabetes and their healthy siblings.

Authors:  Jannet Svensson; Stefanie Eising; David Michael Hougaard; Henrik Bindesbøl Mortensen; Kristin Skogstrand; Lars Bjarke Simonsen; Bendix Carstensen; Anita Nilsson; Åke Lernmark; Flemming Pociot; Jesper Johannesen
Journal:  Hum Immunol       Date:  2012-08-17       Impact factor: 2.850

6.  Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes.

Authors:  Christian Pfleger; Henrik B Mortensen; Lars Hansen; Christian Herder; Bart O Roep; Hillary Hoey; Henk-Jan Aanstoot; Mirjana Kocova; Nanette C Schloot
Journal:  Diabetes       Date:  2008-02-25       Impact factor: 9.461

7.  Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.

Authors:  Lesley A Stevens; Josef Coresh; Christopher H Schmid; Harold I Feldman; Marc Froissart; John Kusek; Jerome Rossert; Frederick Van Lente; Robert D Bruce; Yaping Lucy Zhang; Tom Greene; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2008-03       Impact factor: 8.860

8.  Roles of cytokines in the pathogenesis and therapy of type 1 diabetes.

Authors:  Alex Rabinovitch; Wilma L Suarez-Pinzon
Journal:  Cell Biochem Biophys       Date:  2007       Impact factor: 2.194

9.  Poor glycemic control is associated with low BMD detected in premenopausal women with type 1 diabetes.

Authors:  K K Danielson; M E Elliott; T LeCaire; N Binkley; M Palta
Journal:  Osteoporos Int       Date:  2008-10-02       Impact factor: 4.507

10.  Diabetes in non-Hispanic white youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study.

Authors:  Ronny A Bell; Elizabeth J Mayer-Davis; Jennifer W Beyer; Ralph B D'Agostino; Jean M Lawrence; Barbara Linder; Lenna L Liu; Santica M Marcovina; Beatriz L Rodriguez; Desmond Williams; Dana Dabelea
Journal:  Diabetes Care       Date:  2009-03       Impact factor: 19.112

View more
  2 in total

1.  Dominant TNFα and impaired IL-2 cytokine profiles of CD4+ T cells from children with type-1 diabetes.

Authors:  Julia Seyfarth; Katharina Förtsch; Heinz Ahlert; Hans-Juergen Laws; Beate Karges; Rene Deenen; Karl Köhrer; Ertan Mayatepek; Thomas Meissner; Marc Jacobsen
Journal:  Immunol Cell Biol       Date:  2017-04-05       Impact factor: 5.126

2.  Dermal fibroblasts cultured from donors with type 2 diabetes mellitus retain an epigenetic memory associated with poor wound healing responses.

Authors:  Aaiad H A Al-Rikabi; Desmond J Tobin; Kirsten Riches-Suman; M Julie Thornton
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.